Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Hum Genet. 2001 Nov;69(5):1127-33. Epub 2001 Sep 10.

Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans.

Author information

  • 1Department of Pediatrics, University Hospital and General Hospital of Vienna, A-1090 Vienna, Austria.

Abstract

Arginine:glycine amidinotransferase (AGAT) catalyzes the first step of creatine synthesis, resulting in the formation of guanidinoacetate, which is a substrate for creatine formation. In two female siblings with mental retardation who had brain creatine deficiency that was reversible by means of oral creatine supplementation and had low urinary guanidinoacetate concentrations, AGAT deficiency was identified as a new genetic defect in creatine metabolism. A homozygous G-A transition at nucleotide position 9297, converting a tryptophan codon (TGG) to a stop codon (TAG) at residue 149 (T149X), resulted in undetectable cDNA, as investigated by reverse-transcription PCR, as well as in undetectable AGAT activity, as investigated radiochemically in cultivated skin fibroblasts and in virus-transformed lymphoblasts of the patients. The parents were heterozygous for the mutant allele, with intermediate residual AGAT activities. Recognition and treatment with oral creatine supplements may prevent neurological sequelae in affected patients.

PMID:
11555793
[PubMed - indexed for MEDLINE]
PMCID:
PMC1274356
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk